English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
How azacitidine works
Share :
ASH 50th annual meeting 2008
6 - 9 Dec 2008
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
19 Feb 2009
Views:
21343
Rating:
Save
Rate video
Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York
How azacitidine / vidaza works, epigenetics and vidaza, the difference vidaza makes for patients. Interviewed at ASH 2008.
Categories:
Haematology oncology
Biology
Drug development
Related Videos
Daratumumab, bortezomib/thalidomide/dexamethasone (D-VTd) and DARA maintenance...
Dr Jill Corre - IUCT Oncopole, Toulouse, France
29 Oct 2024
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Dr Elias Mai - Heidelberg University, Heidelberg, Germany
28 Oct 2024
Treating relapsed multiple myeloma outside of use of T-cell redirected therapies
Prof Joy Ho - The University of Sydney, Sydney, Australia
28 Oct 2024
Guiding transplant decisions in multiple myeloma with MRD
Dr Susan Bal - University of Alabama at Birmingham, Birmingham, USA
28 Oct 2024
Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS...
Prof Salomon Manier - Hospital Center University De Lille, Lille, France
30 Sep 2024
Isa-KRd quad regimen in NDMM: MIDAS and CONCEPT studies
Prof Philippe Moreau - University Hospital of Nantes, Nantes, France
30 Sep 2024
Addressing the rise of multiple myeloma in Rwanda
Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda
6 Aug 2024
Glofit-GemOx shows clinically meaningful benefit in relapsed/refractory diffuse...
Dr Jeremy Abramson - Mass General Cancer Center, Boston, USA
9 Jul 2024
TP53 mutations are linked to unfavourable prognosis in chronic lymphocytic...
Dr Consuelo Bertossi - University Hospital of Ulm, Ulm, Germany
27 Jun 2024
More from
e
cancer